Conmana Versus Pemetrexed-based First-line Induction and Maintenance Chemotherapy in Advanced Lung Adenocarcinoma With EGFR-mutation
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 11 Oct 2016
At a glance
- Drugs Icotinib (Primary) ; Cisplatin; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- Acronyms Convince
- Sponsors Betta Pharmaceuticals Co Ltd; Zhejiang Beta Pharma
- 11 Oct 2016 Primary endpoint (Progression Free Survival) has been met, according to results presented at the 41st European Society for Medical Oncology Congress.
- 11 Oct 2016 Results assessing efficacy and safety presented at the 41st European Society for Medical Oncology Congress.
- 29 Sep 2016 Planned End Date changed from 1 Mar 2016 to 1 Dec 2016.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History